Avadel Pharmaceuticals (AVDL) Free Cash Flow (2016 - 2022)
Historic Free Cash Flow for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q4 2022 value amounting to -$15.4 million.
- Avadel Pharmaceuticals' Free Cash Flow rose 3172.49% to -$15.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$71.0 million, marking a year-over-year increase of 816.7%. This contributed to the annual value of -$46.9 million for FY2024, which is 6349.96% up from last year.
- As of Q4 2022, Avadel Pharmaceuticals' Free Cash Flow stood at -$15.4 million, which was up 3172.49% from -$7.5 million recorded in Q3 2022.
- Avadel Pharmaceuticals' Free Cash Flow's 5-year high stood at -$1.4 million during Q2 2019, with a 5-year trough of -$34.0 million in Q1 2022.
- Its 5-year average for Free Cash Flow is -$15.9 million, with a median of -$16.7 million in 2018.
- Per our database at Business Quant, Avadel Pharmaceuticals' Free Cash Flow tumbled by 52128.44% in 2018 and then soared by 9276.71% in 2019.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Free Cash Flow stood at -$24.5 million in 2018, then soared by 66.37% to -$8.3 million in 2019, then tumbled by 132.52% to -$19.2 million in 2020, then dropped by 17.28% to -$22.5 million in 2021, then soared by 31.72% to -$15.4 million in 2022.
- Its last three reported values are -$15.4 million in Q4 2022, -$7.5 million for Q3 2022, and -$14.1 million during Q2 2022.